Source: iQoncept / Shutterstock
Orthofix Medical (NASDAQ:OFIX) recently unveiled the financial snapshot of its fourth quarter for the year 2023.
- The company experienced a setback in earnings per share, reporting a figure of -59 cents. This figure missed the analyst predictions for EPS of -8 cents.
- However, on the revenue front, Orthofix Medical demonstrated resilience, achieving a revenue of $200.42 million.
- Notably, this revenue figure surpassed analyst expectations by 2.61%, which were pegged at $195.31 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/ofix-stock-earnings-orthofix-medical-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC